Inhaled and Systemic Steroids for Bronchopulmonary Dysplasia: Targeting Inflammation and Oxidative Stress
Bronchopulmonary dysplasia (BPD) remains a significant complication of preterm birth, characterized by impaired alveolar and vascular development, chronic lung inflammation, and long-term respiratory morbidity. Corticosteroids, both systemic and inhaled, have been widely investigated as potential th...
Saved in:
| Main Authors: | Francesca Galletta, Alessandra Li Pomi, Sara Manti, Eloisa Gitto |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Antioxidants |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3921/14/7/869 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influence of antenatal steroids on the effect of early inhaled postnatal corticosteroids: a post-hoc analysis of the NEuroSIS trial
by: Jehudith Fontijn, et al.
Published: (2025-03-01) -
Criteria for the duration of anti-inflammatory therapy in children with bronchopulmonary dysplasia
by: Т. І. Stepanenko, et al.
Published: (2019-04-01) -
Inhaled nitric oxide as an independent intervention to lower the risk of bronchopulmonary dysplasia in preterm infants (< 33 weeks) with pulmonary hypertension within the initial 3 days of life
by: Tasnim Azad, et al.
Published: (2025-07-01) -
Elevated visfatin levels illuminate the inflammatory path in bronchopulmonary dysplasia
by: Berna Hoti, et al.
Published: (2024-12-01) -
Bronchopulmonary Dysplasia: a Modern View on Course and Outcomes
by: K. A. Kazakova
Published: (2016-11-01)